Clinical Trial Update: Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating oral ISM5411 for active ulcerative colitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ISM5411

Snippet

Sponsor: InSilico Medicine Hong Kong Limited | Conditions: Ulcerative Colitis | Phase 2 | Status: RECRUITING